rdf-syntax-grammar
mods:
  schema location: http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
  title info:
    title: Multiple Myeloma and Other Plasma Cell Neoplasms
  name:
    name part: Dimopoulos, Meletios A.
    role:
      role term: editor.
    role:
      role term: edt
    role:
      role term: http://id.loc.gov/vocabulary/relators/edt
  name:
    name part: Facon, Thierry.
    role:
      role term: editor.
    role:
      role term: edt
    role:
      role term: http://id.loc.gov/vocabulary/relators/edt
  name:
    name part: Terpos, Evangelos.
    role:
      role term: editor.
    role:
      role term: edt
    role:
      role term: http://id.loc.gov/vocabulary/relators/edt
  name:
    name part: SpringerLink (Online service)
  type of resource: text
  origin info:
    place:
      place term: gw
    date issued: 2018
    edition: 1st ed. 2018.
    issuance: monographic
  language:
    language term: eng
  physical description:
    form: electronic
    form: electronic resource
    reformatting quality: access
    form: remote
    extent: VI, 245 p. 14 illus. in color. online resource.
  abstract: This book is a comprehensive source of up-to-date information on plasma cell neoplasms. Key features include the provision of new criteria for the diagnosis of symptomatic multiple myeloma requiring treatment and the description of novel therapies for myeloma and other plasma cell neoplasms that have only very recently been licensed by the U.S. Food and Drug Administration. Examples include lenalidomide as first-line therapy, panobinostat in combination with bortezomib plus dexamethasone for relapsed/refractory myeloma, ibrutinib for Waldenström's macroglobulinemia, and new therapeutic regimens for systemic amyloidosis and POEMS syndrome. Information is also provided on drug combinations that have shown encouraging results and are very near to approval. Other important aspects covered in the book are the role of different imaging modalities in workup and the significance of newly acquired data relating to prognosis and minimal residual disease. Readers will find Multiple Myeloma and Other Plasma Cell Neoplasms to be a rich source of knowledge that will be invaluable in improving patient management. .
  note: edited by Meletios A. Dimopoulos, Thierry Facon, Evangelos Terpos.
  subject:
    topic: Hematology
  subject:
    topic: Oncology
  subject:
    topic: Immunology
  subject:
    topic: Hematology
  subject:
    topic: Oncology
  subject:
    topic: Immunology
  classification: RB45
  classification: 616.15
  related item:
    title info:
      title: Springer eBooks
  related item:
    title info:
      title: Hematologic Malignancies
  identifier: 9783319255866
  identifier: https://doi.org/10.1007/978-3-319-25586-6
  record info:
    record creation date: 180216
    record change date: 20190619232100.0
    record identifier: 978-3-319-25586-6